Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. - Wikidata - wikimedia - TriplyDB

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

http://www.wikidata.org/entity/Q53192635

about

Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure Diagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasis Psoriasis and cardiovascular risk: strength in numbers Psoriasis and hypertension severity: results from a case-control study.Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients.Risk of cardiovascular disorders in psoriasis patients: current and future.Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies.Which Psoriasis Patients Develop Psoriatic Arthritis?Psoriasis and comorbidities: links and risks.Trends in lipid profiles in patients with psoriasis: a population-based analysis.Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initia Malaysian Clinical Practice Guideline for the Management of Psoriasis Vulgaris: Summary of recommendations for management in primary healthcare setting.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.Attributable risk estimate of severe psoriasis on major cardiovascular events Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study Psoriasis and increased prevalence of hypertension and diabetes mellitus.Cardiovascular comorbiditiy in psoriasis A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis.Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.Associations between cardiovascular risk factors and psoriasis in Iran.A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study Risk and predictors of cardiovascular disease in psoriasis: a population-based study.Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study.Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.Metabolic syndrome in patients with psoriatic disease.Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris.

P2860

Q21135505-DF4A6C95-F198-4B44-AA0C-1DD2D1CF44BC Q26744434-CF5B35F0-35A4-4B1C-B7FE-79D4C75D8981 Q26823443-4400D6E8-551E-4BBB-B51F-D9DC1024FD21 Q33558495-BA5E6080-4E9D-4986-A787-A712B4482C69 Q33558550-C8032EE2-AE0F-4E21-8385-1E78216D8F6F Q33835705-156F9DB5-B5D3-4656-A82B-8E86FD6CBDB3 Q33867611-7EC747AE-DF50-4771-A3FC-6AD409140020 Q33951592-5AF33C66-0CE7-4A2A-8944-0BA0A50C7AED Q34050825-032A5122-46FE-480F-8C24-B227E7EF24E1 Q34323212-BE172B8D-0EFD-4DF6-AC34-0DEF85929A9B Q34381490-CA6BEB15-113A-4473-93A9-F8D70D6CABF4 Q34386985-33F27A0D-CCC2-4E84-B289-59DB2279604B Q34418506-D6980F9D-F620-47D3-AAD4-68D9EA5CD0F0 Q34461243-8FFA3650-0A11-42FF-B58C-9F3852CA7883 Q34638027-E7C8597E-CD94-4593-8D97-238A03F64235 Q34668556-E9A9DDB6-BC5D-45E5-9086-812A90F87B25 Q34699605-88DB6B43-7FFE-42FE-B772-D7AF317BB338 Q34721703-DE55631C-CCB3-4192-B091-389DCE4B0217 Q34812877-89504CD8-602B-40CD-B791-FB2CF06AD255 Q35135113-7C837E73-B8E1-4689-9D6D-D3F72ACFAA30 Q35168945-3483CCC7-0308-4D7E-95D6-0FECBE43EABD Q35171276-6211F294-3878-4D8F-8DF0-29287DDA66F2 Q35564637-13D678ED-6F2D-4E3E-BE3F-CF97C7EB2514 Q35564655-2302B3AF-D434-44F0-9B21-64C386F2EBB3 Q35711283-4767E98D-8F38-45C4-B948-16CE6B0A1968 Q35770123-EBAEB0B1-1BA2-4CD2-9867-957B6BB469AA Q35854188-1B63E642-B74E-450E-BD38-93781C8E061D Q35954321-6A5C1691-B3A4-4607-801E-4DB55977C429 Q36012185-B177034F-B716-4B73-9A6C-21E459CA762A Q36091617-5F92F309-DE53-4CC6-A3A1-1741D1B1256D Q36110025-AA20BF69-A8D8-410A-A9D2-2E1EABE548CF Q36299948-A2B7E59A-1522-4F57-9043-41D5420F16B4 Q36326833-F523F5CA-B7D4-4A46-BBF2-7B01C433AC84 Q36515160-E4220885-D66B-4E26-9DEA-476AF260BA1E Q36610499-6510E511-21F8-4133-80B0-A95A6EE6137F Q36761374-5BA825FE-99F5-4D9B-A58C-51810A2DBF4E Q36824796-BAFEA04C-7FAA-4650-BB07-E0C739EA7D27 Q36897095-A2C3327C-B5B3-435D-8039-40383FD4B483 Q36914874-42912ABE-3212-462E-A097-6958DFFFB5B9 Q36976510-B582403C-8EB0-4E31-BEB1-5F740BD45B68

P2860

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

http://www.wikidata.org/entity/Q53192635

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Association of psoriasis with ...... scular diseases and mortality.

@en

Association of psoriasis with ...... scular diseases and mortality.

@nl

type

label

Association of psoriasis with ...... scular diseases and mortality.

@en

Association of psoriasis with ...... scular diseases and mortality.

@nl

prefLabel

Association of psoriasis with ...... scular diseases and mortality.

@en

Association of psoriasis with ...... scular diseases and mortality.

@nl

P1433

Q53192635-64D27CB7-00DE-4004-B782-B09B78FE168E

P1476

Q53192635-57C94824-BC17-46DC-826B-C37F65A3EA70

P2093

Q53192635-96D6D3E2-A127-4609-8404-1212F92CB874

Q53192635-9876B4C0-A559-40A9-A550-A87E91A277A0

Q53192635-A2239C9A-2B5A-4EA8-B5C9-8EA27BCB637E

Q53192635-C0D96678-E96D-4841-B10F-996CA00690EA

Q53192635-CDE2A562-F9F6-4320-AF7E-D86AF573B1D5

Q53192635-F7122A18-572B-44C6-8CCA-20ADCF4711D0

P304

Q53192635-4EE9704F-1AEF-4FB5-AF26-F139F74F6BD5

P31

Q53192635-5CA0725F-E982-490D-9B7E-87E6950E9A85

P356

Q53192635-482E174F-2E9E-4CBF-9973-63444ACC86D2

P433

Q53192635-C5BC415D-80B8-4AFF-A5D8-8CD6A4F2A2B6

P478

Q53192635-D11D6328-6CB4-42D9-BBEE-59CEBA27BA62

P577

Q53192635-8F932D45-1FD3-4F0D-912B-073C6C1CC6E8

P5875

Q53192635-EE764974-B14F-4473-94F8-1405A0BB3299

P698

Q53192635-CCA0B6BB-9E7B-4BC6-897E-D62941E160BD

P356

ARCHDERMATOL.2009.94

P1433

JAMA Dermatology

P1476

Association of psoriasis with ...... scular diseases and mortality.

@en

P2093

Daniel G Federman

http://www.w3.org/2001/XMLSchema#string

Fangchao Ma

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Kravetz

http://www.w3.org/2001/XMLSchema#string

Lisa Martinez

http://www.w3.org/2001/XMLSchema#string

Robert S Kirsner

http://www.w3.org/2001/XMLSchema#string

Srjdan Prodanovich

http://www.w3.org/2001/XMLSchema#string

P304

700-703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHDERMATOL.2009.94

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26293942

http://www.w3.org/2001/XMLSchema#string

P698

19528427

http://www.w3.org/2001/XMLSchema#string